Silvercrest Investment Holdings

Silvercrest Investment Holdings is a private investment firm based in South Africa that specializes in the healthcare and life sciences sectors. The company is most notable for leading the consortium that acquired the core pharmaceutical and medical device divisions of Ascendis Health during its 2021-2022 restructuring. Through these assets, Silvercrest manages a broad portfolio of branded and generic medicines, as well as high-end medical equipment used in surgical and diagnostic procedures. The firm focuses on optimizing healthcare supply chains and expanding the availability of essential medical products across Sub-Saharan Africa. Its strategic approach involves active management of its subsidiaries to drive operational efficiency and market penetration in the pharmaceutical industry.